Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.
Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.
The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.
2013 US Tumor Marker Testing Market: Opportunities and Strategies for Suppliers
US$ 6,960.00
Highlights This new 620-page analysis of the US tumor marker testing market report from Venture Planning Group including: Major issues ... installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation technologies and feature comparison of leading analyzers. ...
December 2012
620 pages
UK Tumor Marker Testing Market: Innovative Technologies and Emerging Business Opportunities
US$ 4,320.00
Highlights Comprehensive 575-page analysis of the UK tumor marker testing market. Major issues pertaining to the UK laboratory practice, as well as key economic, ... , lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts over for 40 ...
December 2012
575 pages
US Tumor Marker Testing Market: Innovative Technologies and Emerging Business Opportunities
US$ 6,960.00
Highlights Comprehensive 620-page analysis of the US tumor marker testing market. Major issues pertaining to the US laboratory practice, as well as key economic, ... , lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts over for 40 ...
December 2012
620 pages
Innovative CA Tumor Marker Tests Technologies and Emerging Markets
US$ 3,880.00
... and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for ...
November 2012
278 pages
Innovative Cancer Diagnostic Technologies and Emerging Markets
US$ 18,960.00
... market players and potential entrants; and suggests alternative business expansion strategies for suppliers. The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the ...
November 2012
1200 pages
Analysis of Cancer Diagnostic Technologies And Strategic Profiles of Leading Suppliers
US$ 2,800.00
... as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics ...
September 2012
185 pages
Cancer Generics Market Analysis
US$ 1,000.00
Across the globe, oncology market, one of the fastest growing segments of pharmaceutical industry, has been expanding on back of rising cancer incidences, and hefty investment by private players. Acco...
June 2012
75 pages
2012 Global Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies
US$ 22,800.00
... genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the ... identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next ten years; examines trends in the ...
April 2012
1200 pages
2012 France Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies
US$ 4,320.00
This report presents a comprehensive analysis of the French cancer diagnostics market, including: Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...
April 2012
585 pages
2012 Germany Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies
US$ 4,320.00
This report presents a comprehensive analysis of the German cancer diagnostics market, including: Major issues pertaining to the German laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...
April 2012
585 pages
2012 ItalyCancer Diagnostics Market Outlook: Growth Opportunities and Strategies
US$ 4,320.00
This report presents a comprehensive analysis of the Italian cancer diagnostics market, including: Major issues pertaining to the Italian laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...
April 2012
570 pages
2012 Japan Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies
US$ 5,360.00
This report presents a comprehensive analysis of the Japanese cancer diagnostics market, including: Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. ...
April 2012
590 pages
2012 Spain Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies
US$ 4,320.00
This report presents a comprehensive analysis of the Spanish cancer diagnostics market, including: Major issues pertaining to the Spanish laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...
April 2012
565 pages